Five Star Equities Provides Stock Research on Bally Technologies and Glu Mobile
Continue ReadingTag: equity-research
Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry-s Success
Research Driven Investing Provides Stocks Research on ImmunoGen and Omeros
Continue Reading
U.S. Food and Drug Administration Approved 30% More Drugs in 2012
Research Driven Investing Provides Stocks Research on Athersys and Rexahn Pharmaceuticals
Continue Reading
U.S. Oil Production Hits Highest Level in 20 Years, Projected to Increase an Additional 14% in 2013
Five Star Equities Provides Stock Research on Basic Energy Services and Heckmann
Continue Reading
High Yielding REITs Outperform Broader S&P 500 Index for the Fourth Consecutive Year
Five Star Equities Provides Stock Research on American Capital Agency and Invesco Mortgage Capital
Continue Reading
Gaming Stocks Look to Benefit as New Jersey Could Become Third State to Legalize Online Gambling
Five Star Equities Provides Stock Research on Scientific Games and SHFL Entertainment
Continue Reading
Interest in Gold as a Safe Haven Increases as GDP Contracts for the First Time in 3.5 Years
Five Star Equities Provides Stock Research on Aurizon Mines and Brigus Gold
Continue Reading
FDA Approved a Total of 39 New Drugs in 2012 — Fifteen Year High
Research Driven Investing Provides Stocks Research on AEterna Zentaris and Oncolytics Biotech
Continue Reading
Nevada Casinos Revenues Total $10.86 Billion in 2012 — Third Consecutive Annual Increase
RDInvesting Provides Stock Research on Caesars Entertainment and MGM Resorts International
Continue Reading
Biotechnology Industry Soars in 2012 as FDA Drug Approvals at a 15-Year High
Research Driven Investing Provides Stocks Research on Alnylam and Arena
Continue Reading